NCT01229618 Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer Status COMPLETED Phase PHASE1
NCT01226888 Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer Status TERMINATED Phase N/A
NCT01225471 Novel Peptide Vaccination for Patients With Advanced Prostate Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT01220973 Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer Status COMPLETED Phase PHASE2
NCT01220869 A Study of Degarelix in Taiwanese Patients With Prostate Cancer Status COMPLETED Phase PHASE3
NCT01215526 A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer Status COMPLETED Phase N/A
NCT01215513 Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients Status COMPLETED Phase PHASE3
NCT01212991 A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer Status COMPLETED Phase PHASE3
NCT01205646 PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer Status COMPLETED Phase NA
NCT01197625 Vaccine Therapy in Curative Resected Prostate Cancer Patients Status UNKNOWN Phase PHASE1/PHASE2
NCT01193257 Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer. Status COMPLETED Phase PHASE3